2.Oxidative stress and diabetic erectile dysfunction.
Xiao-Xin LI ; Yun CHEN ; Yu-Tian DAI
National Journal of Andrology 2009;15(12):1128-1132
Erectile dysfunction is a common complication of diabetes mellitus, and the pathogenesis of diabetic erectile dysfunction is very complicated, involving neuropathy, neurotransmitters, vasculopathy, vasoactive mediators, metabolism, endocrine and so on. Diabetes mellitus can cause oxidative stress, which plays an important role in the pathogenesis of diabetic complications. This review aims at the role of oxidative stress in the pathogenesis of diabetic erectile dysfunction.
Diabetes Complications
;
metabolism
;
Erectile Dysfunction
;
etiology
;
Humans
;
Male
;
Oxidative Stress
3.Reactive oxygen species and erectile dysfunction.
Qi ZHANG ; Jing-Ya YI ; Xue-Jun SHANG
National Journal of Andrology 2009;15(12):1124-1127
Erectile dysfunction (ED) is one of the common male diseases, which affects 15,200 men in the world. Recent discovery has shown the important role of reactive oxygen species (ROS) in ED. This paper updates the researches on the role of ROS in ED, expounds the relationship of ROS with various risk factors of ED, and outlines the advances in the anti-oxidation treatment of the problem.
Erectile Dysfunction
;
etiology
;
Humans
;
Male
;
Reactive Oxygen Species
4.New progress in etiological factor study and treatment of erectile dysfunction in chronic renal failure patients.
Jian-Jun WU ; Yao DENG ; Shu-Wu ZHANG
National Journal of Andrology 2003;9(4):296-298
Patients with chronic renal failure (CRF) experience a significant decrease in their living quality, due to the limitations imposed by the disease as well as the demands of the treatment that they receive. Some side effects contribute to the morbidity of these patients. Among them, erectile dysfunction (ED) is notable. This article reviews recent advances in etiological factor study and treatment of ED in CRF patients, which may guide the clinic practices in a considerable scale.
Erectile Dysfunction
;
etiology
;
therapy
;
Humans
;
Kidney Failure, Chronic
;
complications
;
Male
5.Multiple sclerosis and erectile dysfunction.
National Journal of Andrology 2009;15(1):56-59
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the human central nervous system. NO, ion channel, cytokine and testosterone play an important role in MS, and may be associated with the pathogenesis of ED. Meanwhile, the relationship between MS-induced peripheral nerve injury and ED should be understood correctly. Further researches on these mediators can provide some theoretical evidence for the clinical treatment of ED.
Erectile Dysfunction
;
etiology
;
metabolism
;
Humans
;
Male
;
Multiple Sclerosis
;
complications
;
metabolism
6.Adequate attention is required to the diagnosis and treatment of mild-symptom erectile dysfunction.
Chun-hua DENG ; Ya-dong ZHANG ; Xin CHEN
National Journal of Andrology 2015;21(1):6-10
Mild-symptom erectile dysfunction (MSED) is commonly seen in clinical practice, but receives inadequate attention from both the patients and clinicians. Increasing researches have indicated that MSED is associated with not only unhealthy living habits and psychological factors but also the early progression of endothelial, metabolic and endocrine diseases. The diagnosis and treatment of MSED should be based on the relevant guidelines, with consideration of both its specific and common features. The therapeutic principle is a combination of integrated and individual solutions aimed at the causes of the disease. Drug intervention should be initiated if psychological therapy fails. Negligence of MSED may affect the quality of life of the patients and their partners, and what's more, might delay the management of some other severe underlying diseases. Adequate attention to the early diagnosis and treatment for MSED is of great significance for a deeper insight into the etiology of ED, the prevention of potential cardiovascular and metabolic diseases, and the improvement of the overall health of males.
Attention
;
Erectile Dysfunction
;
diagnosis
;
etiology
;
therapy
;
Humans
;
Male
;
Quality of Life
7.Impact of chronic diseases on erectile function.
National Journal of Andrology 2014;20(9):834-839
Erectile dysfunction (ED) results from the interaction of many pathological factors. Studies show that a high incidence of ED is associated with chronic diseases of various systems, and its pathogenesis is not fully understood. This article outlines the progress in recent studies on the impact of chronic diseases on erectile function.
Chronic Disease
;
Erectile Dysfunction
;
etiology
;
Humans
;
Male
;
Penile Erection
;
physiology
8.Research Advances on the Relationship between Overt Hyperthyroidism and Risk of Erectile Dysfunction.
Shan-Kun ZHAO ; Mao-Lei SHEN ; Shi-Xiong LIU ; Xin LI
Acta Academiae Medicinae Sinicae 2023;45(1):143-148
Studies have demonstrated the detrimental effects of overt hyperthyroidism on sexual functioning.Here,we comprehensively reviewed the studies that focused on the association between overt hyperthyroidism and erectile dysfunction (ED).After the systematic searching for relevant studies,we find that overt hyperthyroidism is significantly associated with the high risk of ED.The prevalence of ED in patients with hyperthyroidism ranges from 3.05% to 85%,while that in general population is 2.16% to 33.8%.A study reported that the erectile functioning of the hyperthyroidism patients was improved (International Index of Erectile Function:22.1±6.9 vs. 25.2±5.1) after the achievement of euthyroidism.The underlying mechanism of the increase in the risk of ED by overt hyperthyroidism might be correlated to the dysfunction of hypothalamus-pituitary-thyroid axis,dysregulation of sex hormones,abnormal expression of thyroid hormone receptors,and psychiatric or psychological disturbances (e.g.,depression,anxiety,and irritability).Since limited clinical trials have been conducted,additional well-designed cohorts with sizable samples are warranted to elucidate the evidence and mechanism of hyperthyroidism predisposing to ED.The present review indicates that overt hyperthyroidism and the risk of ED are associated,which reminds the clinicians should assess the thyroid stimulating hormone in hyperthyroidism patients presenting with ED,especially in those without positive conventional laboratory findings for causing ED.
Male
;
Humans
;
Erectile Dysfunction/etiology*
;
Anxiety
;
Hyperthyroidism/complications*
;
Thyrotropin
9.Pathogeneses of erectile dysfunction after rectal cancer treatment.
National Journal of Andrology 2014;20(6):558-561
Rectal cancer is a common malignancy in the alimentary tract with an increasing incidence, the current treatments of which include surgery, radiotherapy, chemotherapy, and integrated comprehensive options. Sexual dysfunction, especially erectile dysfunction (ED), is one of the commonest complications in men after rectal cancer treatment and is generally attributed to the damage to the pelvic autonomic nerves. However, recent studies show that ED after rectal cancer treatment is a complex pathophysiological process associated with neurogenic, vasculogenic, and psychological factors. This article reviews the pathogeneses of ED after rectal cancer treatment in order to provide some theoretical evidence for its prevention and treatment.
Erectile Dysfunction
;
etiology
;
Humans
;
Male
;
Postoperative Complications
;
etiology
;
Rectal Neoplasms
;
surgery
10.Transsphenoidal surgery for prolactinomas in male patients: a retrospective study.
Wei-Jie SU ; Hong-Cai CAI ; Guo-Chen YANG ; Ke-Jun HE ; Hong-Lin WU ; Yi-Bing YANG ; Hong-Xing TANG ; Li-Xuan YANG ; Chun-Hua DENG
Asian Journal of Andrology 2023;25(1):113-118
Male patients with prolactinomas usually present with typical hyperprolactinemia symptoms, including sexual dysfunction and infertility. However, clinical factors related to sexual dysfunction and surgical outcomes in these patients remain unclear. This study aimed to investigate the outcomes of male patients with prolactinomas after transsphenoidal surgery and the risk factors affecting sexual dysfunction. This study was conducted on 58 male patients who underwent transsphenoidal surgery for prolactinomas between May 2014 and December 2020 at the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. We evaluated the sexual function of patients before and after surgery through International Index of Erectile Function-5 scores, libido, and frequency of morning erection. Of the 58 patients, 48 (82.8%) patients had sexual intercourse preoperatively. Among those 48 patients, 41 (85.4%) patients presented with erectile dysfunction. The preoperative International Index of Erectile Function-5 scores in patients with macroprolactinomas were significantly higher than those in patients with giant prolactinomas (17.63 ± 0.91 vs 13.28 ± 1.43; P = 0.01). Postoperatively, the incidence of erectile dysfunction was 47.9%, which was significantly lower than that preoperatively (85.4%; P = 0.01). Twenty-eight (68.3%) patients demonstrated an improvement in erectile dysfunction. Tumor size and invasiveness were significantly correlated with the improvement of erectile dysfunction. Preoperative testosterone <2.3 ng ml-1 was an independent predictor of improvement in erectile dysfunction. In conclusion, our results indicated that tumor size and invasiveness were important factors affecting the improvement of sexual dysfunction in male patients with prolactinoma. The preoperative testosterone level was an independent predictor related to the improvement of erectile dysfunction.
Humans
;
Male
;
Prolactinoma/surgery*
;
Erectile Dysfunction/etiology*
;
Retrospective Studies
;
Sexual Dysfunction, Physiological/complications*
;
Testosterone
;
Pituitary Neoplasms/pathology*